Healthy Living South Dakota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living South Dakota.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on November 5, 2025

November 5, 2025

Alpha Pro Tech, Ltd. Announces Third Quarter 2025 Financial Results

GlobeNewswire

November 5, 2025

NewGenDigital Appointed as SAXA Inc.’s Agent for Tokenization of US$100 Million of Gold-backed Assets

GlobeNewswire

November 5, 2025

StoryMD Launches “My StoryMD Journeys,” an AI-Powered Health Platform That Transforms an Individual’s Fragmented Medical Records into a Unified and Personalized Health Narrative

GlobeNewswire

November 5, 2025

Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial

GlobeNewswire

November 5, 2025

Solana Company (NASDAQ: HSDT) Releases Investor Update

GlobeNewswire

November 5, 2025

Standard Dental Labs Signs Binding Agreement to Acquire Dream Dentistry Labs, LLC, Strengthening Central Florida Operations

GlobeNewswire

November 5, 2025

BiomX to Report Third Quarter 2025 Financial Results and Program Updates on November 12, 2025

GlobeNewswire

November 5, 2025

Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025

GlobeNewswire

November 5, 2025

Project C.U.R.E. Bridge the Global Healthcare Divide with Mission-Driven Innovation with Microsoft

GlobeNewswire

November 5, 2025

Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.

GlobeNewswire

November 5, 2025

Tempest Reports Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire

November 5, 2025

iAnthus Continues Expansion in Florida with GrowHealthy Dispensary Opening in Fort Myers

GlobeNewswire

November 5, 2025

YD Bio and EG BioMed Expand U.S. Access to OkaiDx™, a cfDNA‑Methylation Blood Test for Post‑Treatment Breast Cancer Monitoring

GlobeNewswire

November 5, 2025

Normunity announces first patient dosed in Phase 1 clinical study of NRM-823, a T Cell Engager against a novel tumor-specific target, in patients with solid tumors

GlobeNewswire

November 5, 2025

Nexalin Technology’s Q-Submission for Gen-2 SYNC Accepted by U.S. FDA for the Treatment of Alzheimer’s Disease and Dementia

GlobeNewswire

November 5, 2025

Arch Biopartners Expands Phase II Cardiac Surgery-Associated AKI Trial to Include Royal Columbian Hospital in British Columbia

GlobeNewswire

November 5, 2025

Jupiter Neurosciences Receives FDA Clearance of IND Application to Initiate Phase 2a Clinical Trial of JOTROL™ in Parkinson’s Disease

GlobeNewswire

November 5, 2025

MaxCyte Reports Preliminary Third Quarter 2025 Financial Results and Reiterates Full Year 2025 Revenue Guidance

GlobeNewswire

November 5, 2025

STRATA Skin Sciences to Report Third Quarter 2025 Financial Results on November 13, 2025 and Provide Corporate Update

GlobeNewswire

November 5, 2025

CERo Therapeutics Initiates Second Cohort of Phase 1 Clinical Trial of CER-1236 in AML with Patient Receiving Significant Increase in Dosing

GlobeNewswire